Behavioral Pharmacology at EB 2009
Student / post-doc best poster award winners from the EB '09
meeting
1st place post-doc: Greg T. Collins (University of
Michigan)
|
2nd place post-doc: Jun-Xu Li (University of Texas Health
Sciences Center at San
Antonio)
|
1st place graduate student: Robert W. Gould (Wake Forest)
|
2nd place graduate student: tie between Jennifer B. Dwyer
(University of California - Irvine) and Remy Brim (University of Michigan)
|
EB '09 Programs
Pharmacological Imaging in Behavioral Pharmacology and
Drug Development
Chairs: Leonard L. Howell and Mike A.
Nader
Pharmacological MRI in awake rats: application for drug
discovery and development Chih-Liang Chin, Abbott
Laboratories
|
Pharmacological MRI studies of the dopaminergic system in
rhesus monkeys Zhiming Zhang, University of Kentucky
|
Functional neuroimaging and cocaine medication development
in nonhuman primates Leonard L. Howell, Emory Universit
|
PET studies of stimulant drugs in humans Joanna S.
Fowler, Brookhaven National
Laboratorie
|
Advances in Down Syndrome Neuroscience Research:
Implications for Alzheimer's Disease, Dementias and Other Cognitive Disorders
Chairs: Tim A. Esbenshade and Alberto Costa
Down syndrome: A genetic disorder in biobehavioral
perspective Lynn Nadel, University of Arizona
|
Human chromosome 21/Down syndrome gene function:
Implications for cognitive development and Alzheimer's disease Kathleen
Gardiner, University of Colorado Denver in Aurora
|
Structural and functional changes at the synapse
associated with Down syndrome and Alzheimer's disease Craig C. Garner, Stanford
University
|
Evidence for NMDA receptor dysfunction in Down Syndrome:
implications for a potential pharmacotherapy Alberto Costa, University of
Colorado Health Sciences
Center
|
Emerging Approaches to Treatment of Alzheimer's Disease
Chairs: Randy Strong and Greg A. Gerhardt
Current status of treatment of Alzheimer's and related
neurodegenerative diseases Randy Strong and Greg A. Gerhardt, University of
Texas Health Science Center Barshop Institute for Longevity & Aging Studies
& University of
Kentucky
|
Understanding angiogenic dysregulation in Alzheimer's
disease: opening the door for new therapeutic strategies in AD Gregory A.
Jicha, University of
Kentucky
|
Pathways of amyloid-beta toxicity: Potential novel
targets for intervention in Alzheimer's disease Veronica Galvan, The Buck
Institute for Aging
Research
|
The effect of anti-Aß interventions on tau pathology Salvatore Oddo, University of Texas Health Science Center, San Antonio
|
Steroid hormone receptor signaling and Alzheimer's
disease Meharvan Singh, University of North Texas Health Science Center, Fort
Worth
|
The Role of Insulin and Leptin in Drug Addiction and
Mood
Chairs: Charles P. France and Lynette C. Daws
Insulin, leptin, and food reward Dianne P. Figlewicz
Lattemann, University of Washington Health Science Center
|
The role of leptin signaling in emotional behavior Xin-Yun Lu, University of Texas Health Science Center at San Antonio
|
DAT depends on what you eat: Neurochemical and behavioral
effects of amphetamine are dependent on insulin status Lynette C. Daws,
University of Texas Health Science Center at San Antonio
|
The role of leptin on human body weight regulation,
endocrine function, and neurobehavioral outcomes Gilberto Paz-Filho, University
of Miami School of Medicine
|